Preprint Article Version 1 Preserved in Portico This version is not peer-reviewed

Synergistic effect of postbiotic yeast ABB C22® on gut in-flammation, barrier function and protection from Rotavirus in-fection

Version 1 : Received: 9 April 2024 / Approved: 10 April 2024 / Online: 10 April 2024 (10:56:20 CEST)

How to cite: Carrera Marcolin, L.; Cuñé Castellana, J.; Martí Melero, L.; de Lecea, C.; Tintoré Gazulla, M. Synergistic effect of postbiotic yeast ABB C22® on gut in-flammation, barrier function and protection from Rotavirus in-fection. Preprints 2024, 2024040696. https://doi.org/10.20944/preprints202404.0696.v1 Carrera Marcolin, L.; Cuñé Castellana, J.; Martí Melero, L.; de Lecea, C.; Tintoré Gazulla, M. Synergistic effect of postbiotic yeast ABB C22® on gut in-flammation, barrier function and protection from Rotavirus in-fection. Preprints 2024, 2024040696. https://doi.org/10.20944/preprints202404.0696.v1

Abstract

Diarrhoea is a serious cause of mortality worldwide that can lead to dehydration, gut barrier function impairment, nutrient malabsorption, and alterations of the gut microbiota (dysbiosis). Current solutions for its management, such as oral rehydration salts (ORS), inhibitors of the gut motility, antibiotics, and living probiotics only partially counteract the mechanisms of the disease and do not provide a full coverage of the problem. Potential risks of the use of living probiotic strains, particularly in immunocompromised patients, can be eliminated with the use of tyndallized (heat-killed) postbiotic bacteria and yeast. ABB C22® is a postbiotic combination of three tyndallized yeasts, namely Saccharomyces boulardii, Saccharomyces cerevisiae, and Kluyveromyces marxianus. To assess the action of the postbiotic combination on diarrhoea, immune and gut epithelial cell signaling assays, gut barrier formation assay and rotavirus gene expression assay were performed. ABB C22® showed a strong anti-inflammatory effect, an induction of the build-up of the gut epithelium, and a degree of protection against rotavirus infection. These experimental studies support the use of the postbiotic ABB C22® as a solution for the management of diarrhoea and gastrointestinal conditions, alone or in combination with existing but incomplete treatments.

Keywords

diarrhoea; postbiotic; yeast; inflammation; gut protection; Rotavirus

Subject

Biology and Life Sciences, Biology and Biotechnology

Comments (0)

We encourage comments and feedback from a broad range of readers. See criteria for comments and our Diversity statement.

Leave a public comment
Send a private comment to the author(s)
* All users must log in before leaving a comment
Views 0
Downloads 0
Comments 0
Metrics 0


×
Alerts
Notify me about updates to this article or when a peer-reviewed version is published.
We use cookies on our website to ensure you get the best experience.
Read more about our cookies here.